# Hélène Cannard

> Hélène Cannard is a Series A investor at Finovam Gestion backing Medical and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Finovam Gestion](https://shizune.co/investors/profile/finovam-gestion)
- Total investments: 1
- Last investment: May 2025
- Lead investor: 0%
- Last updated: Aug 2026

Hélène Cannard is a Series A investor at Finovam Gestion focused on Medical and Health Care.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Hemerion | Hemerion is focused on creating innovative cancer treatments. The focus is on cutting-edge methods to treat glioblastoma, the most prevalent and dangerous primary brain tumour. | $2.8M | Series A | May 22, 2025 |  |

1 of 1 investments shown.

## Co-investors
- [Captech Santé](https://shizune.co/investors/profile/captech-sant%C3%A9) — VC Fund, 1 deal together
- [Nord France Amorcage](https://shizune.co/investors/profile/nord-france-amorcage) — VC Fund, 1 deal together

## About Finovam Gestion

VC Fund · Villeneuve, France

Finovam Gestion is an investment company approved by the AMF which takes minority stakes in innovative SMEs with high growth potential.The company, which manages €50M, invests in companies that have developed innovative offers in the following target sectors: Information and Communication Technology, Health and Biotechnologies, Agro-resources andEcotechnologies.Finovam Gestion has built solid relationships with the ecosystem of entrepreneurship (Industrials, Poles of Competitiveness, Incubators, Accelerators, Universities, and Research Centers) in all the sectors that we target in order to be able to source and do emerge the best companies.Among our investors (LPs), we can count BPI France, manufacturers (ADEO, LESAFFRE, TEREOS), banks (BNP Paribas, Caisse d´Epargne, Crédit Agricole) and the Haut de France and Grand-Est regions.

2 contacts available at Finovam Gestion.

| Name | Title | Profile |
| --- | --- | --- |
| Anthony Daccache | Seed Capital Developer - Seed Investment Fund | https://shizune.co/investors/profile/anthony-daccache |
| Hélène Cannard | Member of executive management | https://shizune.co/investors/profile/h%C3%A9l%C3%A8ne-cannard |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Hélène Cannard invest in?

Hélène Cannard invests primarily in Medical and Health Care startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Hélène Cannard last invest?

The most recent investment recorded for Hélène Cannard closed in May 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co